JeffreyApterMD

Psychiatry • Princeton, NJ

Medical Director Princeton Medical Institute

Join to view full profile

Dr. Apter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Apter's full profile

Already have an account?

Office
256 Bunn Dr
Suite 6
Princeton, NJ 08540
Phone+1 609-921-3555

Fax+1 609-921-3620

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Psychiatry, 1976 - 1979
University of the WitwatersrandClass of 1974

Certifications & Licensure

IL State Medical License 1977 - Present
NY State Medical License 1983 - Present
NJ State Medical License 1979 - 2025
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder Start of enrollment: 2008 Sep 01
Terminated
Phase 2
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease Start of enrollment: 2008 Oct 01
Completed
Phase 1
PRC-063 in Adolescent ADHD Start of enrollment: 2014 Apr 01
Completed
Phase 3
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD Start of enrollment: 2014 May 01
Completed
Phase 3
A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease Start of enrollment: 2017 Jan 31
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

8 citations
Update on Disease-Modifying/Preventive Therapies in Alzheimer's Disease.
Jeffrey T. Apter, Kuntal Shastri, Katherine Pizano
Current Geriatrics Reports. 2015-07-30
9 citations
Affective-cognitive behavioral therapy for fibromyalgia: a randomized controlled trial.
Robert L. Woolfolk, Lesley A. Allen, Jeffrey T. Apter
Pain Research and Treatment. 2012-01-01
62 citations
Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
Rena Cooper-Kazaz, Jeffrey T. Apter, Revital Cohen, Leonid Karagichev, Said Muhammed-Moussa
Archives of General Psychiatry. 2007-06-01

Press Mentions

Biotechnology Brings New Approach and Fresh Hope to Alzheimer’s ResearchNovember 22nd, 2021
Here Comes a Whole New Approach to Battling Alzheimer’s, and New Jersey Will Play a Lead RoleApril 22nd, 2019
NJ-Based, Minority Woman-Owned Firm Tapped to Promote Alzheimer’s Disease Drug TrialJanuary 10th, 2017